This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
A Brain-Computer Interface (BCI) is a network device that converts brain activity into a desired mechanical action. A modern BCI action would entail the utilization of a brain-activity analyzer and neural networking algorithm to collect, interpret, and translate complicated brain signals for a machine. A robotic arm, a voice box, or any automated assistive equipment, such as prosthetics, wheelchairs, and iris-controlled screen cursors, could be among these machines. Artificial intelligence (AI) and machine learning (ML) in particular enable a better knowledge of brain activity as well as improved brain-computer interface (BCI) connection mechanisms. Early diagnosis and accurate non-pharmacological treatment of neurological diseases and disorders can be achieved by incorporating AI/ML into the data collecting and monitoring phases of neuromodulation or neurofeedback. Furthermore, machine learning allows for the analysis of huge amounts of patient data in order to improve the efficacy of neuromodulation and neurofeedback.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of